insights_auto
Why is ATOS down 2.10%?
Dive Deeperchevron_right
ATOS:NASDAQ
Atossa Therapeutics Inc
$2.39
arrow_downward
-2.10%(-0.051) 1D
$2.40
arrow_upward
+0.47% (+0.011)todayPre-market
Closed: Oct 12, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ATOS...
Open
$2.44
High
$2.53
Low
$2.34
Mkt. cap
23.84M
Avg. vol.
67.66K
Volume
0.00
52-wk high
$17.25
52-wk low
$1.70
EPS
-$4.34
Beta
1.27
Shares outstanding
9.98M
No. of employees
16
Open
$2.44
High
$2.53
Low
$2.34
Mkt. cap
23.84M
Avg. vol.
67.66K
Volume
0.00
52-wk high
$17.25
52-wk low
$1.70
EPS
-$4.34
Beta
1.27
Shares outstanding
9.98M
No. of employees
16
News stories
From web sources and news partners
FXLeaders
·
59 minutes ago
Dow Futures Hold Near 52.2K as Nasdaq Struggles Against Rising Bond Yields
Markets Media
·
20 minutes ago
HKEX Offers S&P 500 & HKEX Tech 100 Index
Benzinga
·
56 minutes ago
Jim Cramer Says ‘Stay In, Keep Buying’ as S&P 500 Surges 118% From 2022 Low — Nvidia Turned $10,000 Into
The Motley Fool
·
1 hour ago
If You Invest $5,000 in VOO Today, Here's What History Says It Could Be Worth in 20 Years
About Atossa Therapeutics Inc
CEOSteven C. Quay
Employees16
Founded2008
HeadquartersSeattle, Washington, United States
SectorBiotechnology
Websiteatossatherapeutics.com